| Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study CMM Prado, JR Lieffers, LJ McCargar, T Reiman, MB Sawyer, L Martin, ... The lancet oncology 9 (7), 629-635, 2008 | 3032 | 2008 |
| International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016 | 2480 | 2016 |
| Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index L Martin, L Birdsell, N MacDonald, T Reiman, MT Clandinin, LJ McCargar, ... Journal of clinical oncology 31 (12), 1539-1547, 2013 | 2399 | 2013 |
| A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care M Mourtzakis, CMM Prado, JR Lieffers, T Reiman, LJ McCargar, ... Applied Physiology, Nutrition, and Metabolism 33 (5), 997-1006, 2008 | 2046 | 2008 |
| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1182 | 2009 |
| Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment CMM Prado, VE Baracos, LJ McCargar, T Reiman, M Mourtzakis, ... Clinical cancer research 15 (8), 2920-2926, 2009 | 1156 | 2009 |
| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 1007 | 2012 |
| Body composition as an independent determinant of 5-fluorouracil–based chemotherapy toxicity CMM Prado, VE Baracos, LJ McCargar, M Mourtzakis, KE Mulder, ... Clinical Cancer Research 13 (11), 3264-3268, 2007 | 687 | 2007 |
| Body composition in patients with non− small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis VE Baracos, T Reiman, M Mourtzakis, I Gioulbasanis, S Antoun The American journal of clinical nutrition 91 (4), 1133S-1137S, 2010 | 537 | 2010 |
| In multiple myeloma, t (4; 14)(p16; q32) is an adverse prognostic factor irrespective of FGFR3 expression JJ Keats, T Reiman, CA Maxwell, BJ Taylor, LM Larratt, MJ Mant, ... Blood, The Journal of the American Society of Hematology 101 (4), 1520-1529, 2003 | 495 | 2003 |
| International Myeloma Working Group recommendations for the treatment of multiple myeloma–related bone disease E Terpos, G Morgan, MA Dimopoulos, MT Drake, S Lentzsch, N Raje, ... Journal of clinical oncology 31 (18), 2347, 2013 | 442 | 2013 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 435 | 2016 |
| Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients KS Courneya, CM Sellar, C Stevinson, ML McNeely, CJ Peddle, ... J Clin Oncol 27 (27), 4605-4612, 2009 | 416 | 2009 |
| Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions LW Jones, CJ Peddle, ND Eves, MJ Haykowsky, KS Courneya, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 395 | 2007 |
| Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving … RA Murphy, M Mourtzakis, QSC Chu, VE Baracos, T Reiman, VC Mazurak Cancer 117 (8), 1775-1782, 2011 | 344 | 2011 |
| New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) EM Ocio, PG Richardson, SV Rajkumar, A Palumbo, MV Mateos, ... Leukemia 28 (3), 525-542, 2014 | 305 | 2014 |
| Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ... Leukemia 30 (5), 1005-1017, 2016 | 290 | 2016 |
| Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer RA Murphy, M Mourtzakis, QSC Chu, VE Baracos, T Reiman, VC Mazurak Cancer 117 (16), 3774-3780, 2011 | 286 | 2011 |
| Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis M Tonelli, B Hemmelgarn, T Reiman, B Manns, MN Reaume, A Lloyd, ... Cmaj 180 (11), E62-E71, 2009 | 275 | 2009 |
| Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ... The Lancet 397 (10292), 2361-2371, 2021 | 251 | 2021 |
